Leadership/Staff

Consortium Leadership Team

Aaron McCabe, Ph.D
Executive/Technical Lead
Minnetronix Neuro

Aaron joined Minnetronix in October of 2012 as Director of Research and Development. In this position, he has been responsible for leading our initiatives at Minnetronix Neuro to research, develop, study, and bring to market the company’s own therapeutic medical devices.

Prior to joining Minnetronix, Aaron spent 14 years in the medical device industry, the majority of which was focused on performing and managing feasibility research in the US and internationally. He was a Principal Scientist and then Senior Manager in the research department at Boston Scientific. At Boston Scientific, his group focused on high and low-voltage therapy, optimization, and automation algorithms for Cardiac Rhythm Management devices. Aaron started his career at Guidant as an Electrical Engineer.

Aaron earned his Bachelor of Science as well as his Master of Science in Electrical Engineering from MIT. He earned his Ph.D. from the University of Minnesota, also in Electrical Engineering. Aaron is named an inventor on more than 60 patents.

Email Aaron at amccabe@minnetronix.com

Dr. Nandan Lad, M.D., Ph.D
Medical/Scientific Lead
Duke University Medical Center

Dr. Nandan Lad is a neurosurgeon, scientist, innovator and currently an Associate Professor of Neurosurgery at Duke University Medical Center with a focus in Neuromodulation. He is the inventor of the Neurapheresis Therapy and serves as the Chief Medical Officer at Minnetronix. Working in partnership with disease experts across the globe, Nandan leads the Consortium’s efforts to advance Neurapheresis Therapy to benefit patients with a variety of challenging neurological indications. His goal is to minimize dependence on long-term medications, improve quality of life and improve function, so that the patient may better adapt to their activities and get back to their normal daily function. He completed his MD and PhD in Biochemistry at Chicago Medical School and his neurosurgical residency and fellowship training in Functional Neurosurgery and Biodesign Innovation at Stanford University. Dr. Lad brings his exceptional technical skills and professionalism to the Consortium. He serves as Director of the Duke NeuroInnovations Program, a systematic approach to innovation to large unmet clinical needs. He also directs the Duke Neuro-Outcomes program, which helps address key health policy questions and patient-centered outcomes.

Email Nandan at nlad@minnetronix.com

Matt Stoll
Commercialization/Funding Lead
Minnetronix Neuro

Matt provides leadership in market research and business development for Minnetronix’ neurocritical care initiatives. He began his career at Minnetronix in 2010 as a Product Manager in Minnetronix’ New Ventures group, managing efforts in remote connectivity and ventricular assist.

Prior to Minnetronix, Matt spent 10 years in various product management roles in the finance and telecommunications industries, commercializing numerous products and managing business lines as large as $30M in annual revenue. He also serves as an Adjunct Instructor at the Carlson School of Management at the University of Minnesota, where he teaches at the MILI Valuation Lab leading students on the evaluation of early-stage innovation in the biologics, pharmaceutical, and medical device industries.

Matt received a Bachelor of Science in Electrical Engineering from Pennsylvania State University, and a MBA from the Carlson School of Management at the University of Minnesota. While at the University of Minnesota, Matt was a Medical Industry Leadership Institute Innovation Fellow.

Email Matt at mstoll@minnetronix.com

Contact NRC for more information about our programs or participation inquiries, contact us.
CAUTION – Investigational Device, limited by Federal Law to Investigational Use.
Minnetronix is a registered trademark, and Neurapheresis is a trademark of Minnetronix, Inc.
©Minnetronix, Inc. All rights reserved.